The potential of convalescent plasma therapy for COVID-19 patients

With researchers around the world racing to develop a vaccine for COVID-19, attention is increasingly turning to a potential stop-gap measure – convalescent plasma. The yellowish gold part of our blood that contains antibodies to help fight viruses is the focus of research in labs and hospitals and shows early signs of promise. John Yang reports.

Stream your PBS favorites with the PBS app:
Find more from PBS NewsHour at
Subscribe to our YouTube channel:

Follow us:
Facebook:
Twitter:
Instagram:
Snapchat: @pbsnews

Subscribe:
PBS NewsHour podcasts:
Newsletters:

coronavirus,treating coronavirus,blood plasma,coronavirus antibodies,covid-19 antibody testing,convalescent plasma therapy,plasma therapy,coronavirus patients,coronavirus vaccine,convalescent plasma,antibody,antibodies,antibodies in blood,blood plasma coronavirus antibodies,science,science news,coronavirus treatment,covid-19 vaccine,flattening the curve,coronavirus pandemic,coronavirus outbreak,covid-19,health news,promising covid-19 news,pbs,pbs newshour,